Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
NCT03568669
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
Congenital central hypoventilation syndrome (CCHS) is a rare disorder of autonomic and respiratory regulation that frequently alters oxygen delivery to the brain. In CCHS, neurocognitive function has been of great concern because of the potential for repeated hypoxemia and hypercarbia in activities of daily living in addition to hypoventilation with related hypoxemia and hypercarbia during sleep.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Congenital Central Hypoventilation Syndrome
- Congenital Central Hypoventilation
- CCHS
- CCHS With Hirschsprung Disease
- CCHS With Neural Crest Tumor
- CCHS With Neuroblastoma
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 3 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Ilya Khaytin
- Last updated on ClinicalTrials.gov
- September 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Children's Hospital Los Angeles · Los Angeles, CA
Illinois · 1
- Ann & Robert H. Lurie Children's Hospital of Chicago · Chicago, IL
Washington · 1
- Seattle Children's Hospital · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.